Truscreen Group Ltd
Truscreen Group Limited is a New Zealand-based medical device company.
The business
Truscreen Group Limited is a New Zealand-based medical device company. The Company is engaged in the development of an artificial intelligence (AI)-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The Company’s cervical screening technology resolves ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure. The TruScreen device uses opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable Single Use Sensor (SUS), a Handheld Device (HHD), and an Intelligent Cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. It also resolves the problems associated with human papillomavirus (HPV) testing, which tests for the much more prevalent HPV virus.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
TruScreen Validated as Superior Cervical Cancer Screening Tool in Major Chinese Study
TruScreen Group (ASX: TRU) announced strong validation results from a major Chinese study for its cervical cancer screening tool, positioning it for guidelin
ASX Investment Opportunities on Show in Singapore During Grand Prix
All roads will lead to Singapore in early October with the important Spark Plus Aussie Equities Day investment show being staged in the lead-up to the local grand prix motoring event. The 2025 Spark Plus Aussie Equities Day is the 4th installment of their flagship event which aims to introduce a range of Australian companies to […]
TruScreen Group launches five-year cervical cancer screening program in Ho Chi Minh City
Sydney-based biotech TruScreen Group (ASX: TRU) has launched a five-year cervical screening program in Vietnam using its artificial intelligence-enabled, non-invasive TruScreen Ultra screening device. The company will conduct the community-based program through a partnership it signed in November with the Ho Chi Minh City Public Health Association (HPHA) and distributor Gorton Health Services (GHS). The […]
TruScreen launches proactive cervical cancer screening initiative in Ho Chi Minh City
Cervical cancer screening device developer TruScreen Group (ASX: TRU) is set to undertake a major screening program with its technology in Vietnam. The Sydney-based company has signed a memorandum of understanding (MoU) to implement and conduct a public cervical cancer screening program in Ho Chi Minh City targeting 260,000 women. The program will implement a […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.